Xaria joined the Neuroinflammation Lab in July 2016. Upon graduating with First Class Honours, she commenced her PhD in 2018 with a goal to identify the novel functions of the enigmatic C5a receptor 2 (C5aR2).
Publications
Journal Articles
Pandey, Shubhi, Maharana, Jagannath, Li, Xaria X., Woodruff, Trent M. and Shukla, Arun K. (2020) Emerging insights into the structure and function of complement C5a receptors. Trends in Biochemical Sciences, .doi:10.1016/j.tibs.2020.04.004
Nabizadeh, Jamileh A., Manthey, Helga D., Panagides, Nadya, Steyn, Frederik J., Lee, John D., Li, Xaria X., Akhir, Fazrena N. M., Chen, Weiyu, Boyle, Glen M., Taylor, Stephen M., Woodruff, Trent M. and Rolfe, Barbara E. (2019). C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanoma. FASEB Journal, 33 (10) fj201800980RR-11071. doi:10.1096/fj.201800980rr
Li, Xaria X., Lee, John D., Kemper, Claudia and Woodruff, Trent M. (2019) The complement receptor C5aR2: a powerful modulator of innate and adaptive immunity. Journal of Immunology, 202 12: 3339-3348. doi:10.4049/jimmunol.1900371
Brennan, Faith H., Jogia, Trisha, Gillespie, Ellen R., Blomster, Linda V., Li, Xaria X., Nowlan, Bianca, Williams, Gail M., Jacobson, Esther, Osborne, Geoff W., Meunier, Frederic A., Taylor, Stephen M., Campbell, Kate E., MacDonald, Kelli P.A., Levesque, Jean-Pierre, Woodruff, Trent M. and Ruitenberg, Marc J. (2019). Complement receptor C3aR1 controls neutrophil mobilization following spinal cord injury through physiological antagonism of CXCR2. JCI Insight, 4 (9) e98254, doi:10.1172/jci.insight.98254
Pandey, Shubhi, Li, Xaria X., Srivastava, Ashish, Baidya, Mithu, Kumari, Punita, Dwivedi, Hemlata, Chaturvedi, Madhu, Ghosh, Eshan, Woodruff, Trent M. and Shukla, Arun K. (2019) Partial ligand-receptor engagement yields functional bias at the human complement receptor, C5aR1. Journal of Biological Chemistry, . doi:10.1074/jbc.ra119.007485
Hawksworth, Owen A., Li, Xaria X., Coulthard, Liam G., Wolvetang, Ernst J. and Woodruff, Trent M. (2017) New concepts on the therapeutic control of complement anaphylatoxin receptors. Molecular Immunology, 89 36-43. doi:10.1016/j.molimm.2017.05.015